OpenVSafe by OpenVAERS
Search V-safe

EM5-26052-99369

3 vaccinations 6 coded responses 28 check-ins 6 free-text entries 0 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
551 / MN
Registered
2021-04-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-02
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-05
    Registered in v-safe
  3. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-09
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-17
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-04-23
    Dose 2 — Pfizer-BioNTech
  10. 2021-04-23
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-04-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  14. 2021-04-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-30
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-05-07
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-14
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-21
    Survey response — day 28, dose 2
    MedDRA: Blindness, Migraine — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Silent migraines with vision loss
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-28
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-06-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-07-23
    Survey response — 3 months, dose 2
    MedDRA: Cough, Eye irritation, Neuralgia, Oropharyngeal pain, Sneezing — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Sore throat, sneezing, cough, burning eyes, nerve pain
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  22. 2021-10-23
    Survey response — 6 months, dose 2
    MedDRA: Gastrointestinal disorder, Ophthalmic migraine — Feeling: Good · Be unable to do your normal daily activities
    Free text: Ocular migraines. And stomach issues that have yet to be diagnosed. N
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-12-20
    Dose 3 — Pfizer-BioNTech
  24. 2021-12-28
    Health check-in — day 7, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  25. 2022-01-03
    Survey response — day 14, dose 3
    MedDRA: Tachycardia — Feeling: Good
    Free text: Increased tachycardia
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-01-10
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  27. 2022-01-17
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  28. 2022-01-24
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-01-31
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-03-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-06-21
    Survey response — 6 months, dose 3
    MedDRA: Alopecia, Migraine, SARS-CoV-2 test positive, Skin ulcer, Vision blurred, Vitreous floaters — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Covid in May that I continually tested positive for for 13 days. Eye floaters increase, blurred vision, a29 day migraine, skin sores, hair loss
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-12-24
    Survey response — 12 months, dose 3
    MedDRA: Rash, Vision blurred, Visual impairment, Vitreous floaters — Feeling: Fair
    Free text: Rashes that come and go. Really bad eye floaters that block - hamper my vision. Blurry vision that comes and goes.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-02Pfizer-BioNTech
22021-04-23Pfizer-BioNTech
32021-12-20Pfizer-BioNTech No

Free text

Release 8 — day 28, dose 2

2021-05-21

Symptoms: Silent migraines with vision loss

Release 9 — 3 months, dose 2

2021-07-23

Symptoms: Sore throat, sneezing, cough, burning eyes, nerve pain

Release 10 — 6 months, dose 2

2021-10-23

Symptoms: Ocular migraines. And stomach issues that have yet to be diagnosed. N

Release 10 — day 14, dose 3

2022-01-03

Symptoms: Increased tachycardia

Release 12 — 6 months, dose 3

2022-06-21

Symptoms: Covid in May that I continually tested positive for for 13 days. Eye floaters increase, blurred vision, a29 day migraine, skin sores, hair loss

Release 12 — 12 months, dose 3

2022-12-24

Symptoms: Rashes that come and go. Really bad eye floaters that block - hamper my vision. Blurry vision that comes and goes.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAlopecia · · ✓
SDBlindness ✓ ✓ ✓
SDCough ✓ · ✓
SDEye irritation ✓ · ✓
SDGastrointestinal disorder · · ✓
SDMigraine ✓ ✓ ✓
SDNeuralgia ✓ · ✓
SDOphthalmic migraine · · ✓
SDOropharyngeal pain ✓ · ✓
SDRash · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSkin ulcer · · ✓
SDSneezing ✓ · ✓
SDTachycardia · · ✓
SDVision blurred · · ✓
SDVisual impairment · · ✓
SDVitreous floaters · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release